LOC105377806: Potential Drug Target and Biomarker (G105377806)
LOC105377806: Potential Drug Target and Biomarker
LOC105377806 is a protein that is found in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the LOC105 family of proteins, which are known for their role in intracellular signaling. In particular, LOC105377806 is involved in the regulation of cell survival and metabolism.
Recent studies have suggested that LOC105377806 may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. This is because of its involvement in several intracellular signaling pathways that are disrupted in these conditions, as well as its potential role in drug resistance.
One of the mechanisms by which LOC105377806 is involved in intracellular signaling is through its role in the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell survival and metabolism, and is often disrupted in diseases such as cancer and neurodegenerative diseases.
Studies have shown that LOC105377806 is a positive regulator of the PI3K/Akt signaling pathway. This means that when levels of PI3K/Akt signaling are increased, LOC105377806 is activated and promotes the growth and survival of cells. In contrast, when levels of PI3K/Akt signaling are decreased, LOC105377806 is inhibited and promotes cell death.
This understanding of LOC105377806's role in PI3K/Akt signaling pathway is important for the development of potential drugs that target this pathway. For example, LOC105377806 has been shown to be a potential drug target for cancer, neurodegenerative diseases, and metabolic disorders.
Another potential mechanism by which LOC105377806 is involved in intracellular signaling is through its role in the NF-kappa-B signaling pathway. This pathway is involved in the regulation of inflammation and immune responses, and is often disrupted in diseases such as cancer and neurodegenerative diseases.
Studies have shown that LOC105377806 is a negative regulator of the NF-kappa-B signaling pathway. This means that when levels of NF-kappa-B signaling are increased, LOC105377806 is inhibited and promotes the growth and survival of cells. In contrast, when levels of NF-kappa-B signaling are decreased, LOC105377806 is activated and promotes cell death.
This understanding of LOC105377806's role in NF-kappa-B signaling pathway is important for the development of potential drugs that target this pathway. For example, LOC105377806 has been shown to be a potential drug target for cancer, neurodegenerative diseases, and metabolic disorders.
In addition to its role in intracellular signaling pathways, LOC105377806 has also been shown to have potential as a biomarker for various diseases. For example, LOC105377806 has been shown to be elevated in the brains of individuals with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
This suggests that LOC105377806 may be a useful biomarker for the diagnosis and treatment of these conditions. Additionally, LOC105377806 has also been shown to be elevated in the blood of individuals with certain metabolic disorders, such as type 2 diabetes.
Overall, LOC105377806 is a protein that is involved in several intracellular signaling pathways that are disrupted in
Protein Name: Uncharacterized LOC105377806
The "LOC105377806 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105377806 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105377809 | LOC105377824 | LOC105377844 | LOC105377845 | LOC105377858 | LOC105377862 | LOC105377864 | LOC105377865 | LOC105377871 | LOC105377876 | LOC105377877 | LOC105377882 | LOC105377891 | LOC105377913 | LOC105377920 | LOC105377923 | LOC105377924 | LOC105377927 | LOC105377941 | LOC105377968 | LOC105377979 | LOC105377981 | LOC105377989 | LOC105378009 | LOC105378010 | LOC105378011 | LOC105378019 | LOC105378022 | LOC105378058 | LOC105378066 | LOC105378072 | LOC105378082 | LOC105378085 | LOC105378088 | LOC105378091 | LOC105378099 | LOC105378105 | LOC105378110 | LOC105378120 | LOC105378145 | LOC105378146 | LOC105378150 | LOC105378178 | LOC105378189 | LOC105378204 | LOC105378206 | LOC105378228 | LOC105378305 | LOC105378310 | LOC105378314 | LOC105378316 | LOC105378318 | LOC105378327 | LOC105378334 | LOC105378335 | LOC105378339 | LOC105378340 | LOC105378342 | LOC105378347 | LOC105378409 | LOC105378414 | LOC105378460 | LOC105378477 | LOC105378486 | LOC105378492 | LOC105378502 | LOC105378508 | LOC105378515 | LOC105378517 | LOC105378520 | LOC105378525 | LOC105378526 | LOC105378537 | LOC105378543 | LOC105378559 | LOC105378560 | LOC105378586 | LOC105378589 | LOC105378596 | LOC105378605 | LOC105378606 | LOC105378617 | LOC105378641 | LOC105378654 | LOC105378657 | LOC105378663 | LOC105378678 | LOC105378693 | LOC105378694 | LOC105378741 | LOC105378750 | LOC105378761 | LOC105378764 | LOC105378776 | LOC105378780 | LOC105378793 | LOC105378797 | LOC105378798 | LOC105378800 | LOC105378841
